Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina Solomon

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2018
Sleep disturbances and dementia risk: A multicenter studyShireen Sindi, Ingemar Kåreholt, Lena Johansson, et al.
European Journal of Neurology|May 11, 2024
Diverging medical and legal perceptions of the need for legal guardianship in people with dementia: A qualitative studyKaisa Näkki, Anna Mäki-Petäjä-Leinonen, Kaijus Ervasti, et al.
European Geriatric Medicine|December 23, 2025
Correction: Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trialMaria Sääskilahti, Emma Aarnio, Esko Levälahti, et al.
Neuroscience Letters|June 30, 2009
Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's diseaseAlina Solomon, Valerio Leoni, Miia Kivipelto, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 27, 2014
Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumesBabak Hooshmand, Johan Lökk, Alina Solomon, et al.
International Psychogeriatrics|March 14, 2025
Associations of depressive symptoms and cortisol with cognitive performance among memory clinic patientsDickson Olusegun Adedeji, Jasper Holleman, Lena Johansson, et al.
European Geriatric Medicine|December 3, 2025
Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trialMaria Sääskilahti, Emma Aarnio, Esko Levälahti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2024
Cognitive reserve, cortisol, and Alzheimer's disease biomarkers: A memory clinic studyManasa Shanta Yerramalla, Alexander Darin-Mattsson, Chinedu T Udeh-Momoh, et al.
Alzheimer'S Research & Therapy|February 25, 2022
Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer's disease: a potential early sign of ADJulen Goikolea, Gorka Gerenu, Makrina Daniilidou, et al.
Alzheimer'S Research & Therapy|March 7, 2021
27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trialAnna Sandebring-Matton, Julen Goikolea, Ingemar Björkhem, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2018
Sleep disturbances and dementia risk: A multicenter studyShireen Sindi, Ingemar Kåreholt, Lena Johansson, et al.
European Journal of Neurology|May 11, 2024
Diverging medical and legal perceptions of the need for legal guardianship in people with dementia: A qualitative studyKaisa Näkki, Anna Mäki-Petäjä-Leinonen, Kaijus Ervasti, et al.
European Geriatric Medicine|December 23, 2025
Correction: Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trialMaria Sääskilahti, Emma Aarnio, Esko Levälahti, et al.
Neuroscience Letters|June 30, 2009
Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's diseaseAlina Solomon, Valerio Leoni, Miia Kivipelto, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 27, 2014
Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumesBabak Hooshmand, Johan Lökk, Alina Solomon, et al.
International Psychogeriatrics|March 14, 2025
Associations of depressive symptoms and cortisol with cognitive performance among memory clinic patientsDickson Olusegun Adedeji, Jasper Holleman, Lena Johansson, et al.
European Geriatric Medicine|December 3, 2025
Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trialMaria Sääskilahti, Emma Aarnio, Esko Levälahti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2024
Cognitive reserve, cortisol, and Alzheimer's disease biomarkers: A memory clinic studyManasa Shanta Yerramalla, Alexander Darin-Mattsson, Chinedu T Udeh-Momoh, et al.
Alzheimer'S Research & Therapy|February 25, 2022
Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer's disease: a potential early sign of ADJulen Goikolea, Gorka Gerenu, Makrina Daniilidou, et al.
Alzheimer'S Research & Therapy|March 7, 2021
27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trialAnna Sandebring-Matton, Julen Goikolea, Ingemar Björkhem, et al.
Pageof 15